Lumenis Announces Fourth Quarter and Fiscal Year 2014 Earnings Conference Call

YOKNEAM, Israel, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (Nasdaq:LMNS), the world's largest medical laser company for surgical, ophthalmology and aesthetic applications, today announced plans to release its fourth quarter and fiscal year 2014 financial results on Thursday, February 12, 2015, before the market opens.

In conjunction with the release, management will host a conference call on Thursday, February 12, 2015, at 8:00 a.m. (Eastern). To listen to the conference call on your telephone, please dial the following numbers approximately ten minutes prior to the start of the call: 888-203-7337 for callers based in the United States, 1-80-924-5905 for callers based in Israel and 719-457-2602 for callers based in all other countries. The reservation code for the call is 3878753. A live webcast of the conference call will also be available on the investor relations page of the company's website at

A telephone replay of the call will be available for 14 days following the call. To listen to the replay, please dial 888-203-1112 for United States-based callers and 719-457-0820 for international callers. The reservation code is 3878753. A replay of the webcast will be available on the investor relations page of the company's website.

About Lumenis

Lumenis (Nasdaq:LMNS) is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. Our drive for innovation stems from an uncompromising commitment to improving the health and well-being of our patients; addressing new and growing needs of aging populations; and in offering medical professionals cutting-edge solutions that fit seamlessly into the health-economics environment of the 21st century. The world over, we bring Energy to Healthcare.

For more information visit:

CONTACT: For Investor Inquiries: Mark Klausner or Michael Piccinino, CFA Westwicke Partners, LLC. 443.213.0500

Source:Lumenis Ltd.